Atossa Therapeutics (ATOS) EPS (Diluted) (2022 - 2026)
Powered by 
Analysis
Atossa Therapeutics (ATOS) EPS (Diluted) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 640.34 Bn | 619.59 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 445.94 Bn | 439.37 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 356.80 Bn | 349.66 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 269.15 Bn | 261.46 Bn | 11.24 Bn | 1.67 |
| 5 | Pfizer | 156.49 Bn | 144.80 Bn | 10.94 Bn | -0.04 |
| 6 | Sanofi | 52.18 Bn | 44.80 Bn | 10.79 Bn | 0.33 |
| 7 | Revolution Medicines | 43.29 Bn | 43.29 Bn | - | -3.06 |
| 8 | Incyte | 24.98 Bn | 20.44 Bn | 1.57 Bn | 2.81 |
| 9 | United Therapeutics | 21.33 Bn | 18.67 Bn | 683.80 Mn | 7.27 |
| 10 | Atossa Therapeutics | 21.56 Mn | 21.56 Mn | - | -0.95 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.95 |
| Mar 31, 2026 | -1.11 |
| Dec 31, 2025 | -0.42 |
| Sep 30, 2025 | -1.01 |
| Jun 30, 2025 | -0.98 |
| Mar 31, 2025 | -0.78 |
| Dec 31, 2024 | -0.12 |
| Sep 30, 2024 | -0.86 |
| Jun 30, 2024 | -0.72 |
| Mar 31, 2024 | -0.70 |
| Dec 31, 2023 | -0.17 |
| Sep 30, 2023 | -0.74 |
| Jun 30, 2023 | -1.16 |
| Mar 31, 2023 | -0.74 |
| Dec 31, 2022 | -0.22 |